Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019)
{{output}}
Introduction: Therapeutic antibodies blocking co-inhibitory pathways do not attack tumor cells directly, but instead bind to their targeted proteins and mobilize the immune system to eradicate tumors. However, only a small fracti... ...